OptimizeRx Corporation OPRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -29.77% | -9.50% | -0.24% | 22.33% | 55.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -29.77% | -9.50% | -0.24% | 22.33% | 55.19% |
| Cost of Revenue | -54.39% | -42.78% | -20.93% | 8.76% | 48.56% |
| Gross Profit | -15.81% | 11.90% | 9.43% | 30.26% | 59.22% |
| SG&A Expenses | 1.56% | -9.28% | -17.40% | 7.16% | -21.68% |
| Depreciation & Amortization | -0.93% | -2.74% | -1.46% | -1.37% | 0.09% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.76% | -19.07% | -18.06% | 7.30% | 15.19% |
| Operating Income | -102.74% | 118.84% | 130.51% | 291.05% | 185.54% |
| Income Before Tax | -163.32% | 80.32% | 238.36% | 110.55% | 133.97% |
| Income Tax Expenses | -297.49% | 86.11% | 7.22% | 133.05% | 118.29% |
| Earnings from Continuing Operations | -145.89% | 77.49% | 6,535.90% | 108.54% | 138.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -145.89% | 77.49% | 6,535.90% | 108.54% | 138.22% |
| EBIT | -102.74% | 118.84% | 130.51% | 291.05% | 185.54% |
| EBITDA | -78.35% | 230.84% | 94.11% | 2,365.91% | 250.32% |
| EPS Basic | -145.17% | 77.83% | 6,504.76% | 108.42% | 137.72% |
| Normalized Basic EPS | -162.50% | 80.58% | 215.50% | 142.22% | 133.49% |
| EPS Diluted | -150.00% | 75.00% | 6,169.05% | 108.00% | 136.36% |
| Normalized Diluted EPS | -164.15% | 80.58% | 203.85% | 140.31% | 132.63% |
| Average Basic Shares Outstanding | 1.48% | 1.57% | 1.32% | 1.38% | 1.39% |
| Average Diluted Shares Outstanding | -1.21% | 1.57% | 5.23% | 6.20% | 4.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |